SARS-CoV-2 (COVID-19) Spike antibody

Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2. Zeng W et al., 2022, Front Cell Infect Microbiol

TMED3 Complex Mediates ER Stress-Associated Secretion of CFTR, Pendrin, and SARS-CoV-2 Spike. Park H et al., 2022 Aug, Adv Sci (Weinh)

SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex. Vasquez V et al., 2022 May 1, Anal Chim Acta

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Ordonez AA et al., 2022 Mar 18, Commun Biol

SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry. Yang B et al., 2022 Jan 25, Proc Natl Acad Sci U S A

Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants. Lin WS et al., 2021, Front Immunol

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge. Meseda CA et al., 2021 Dec 3, NPJ Vaccines

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. Huang HC et al., 2021 Dec, EBioMedicine

Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles. Hsieh MH et al., 2021, Front Immunol

Pharmacological activation of STING blocks SARS-CoV-2 infection. Li M et al., 2021 May 18, Sci Immunol